Ozempic and Wegovy Transform American Healthcare: 15 Million US Prescriptions and Counting
GLP-1 weight loss drugs have become the fastest-adopted medications in American pharmaceutical history, with 15 million active US prescriptions transforming how doctors and patients approach obesity, diabetes, and heart disease.
Novo Nordisk vs. Eli Lilly: The Battle to Dominate America's $100 Billion Weight Loss Drug Market
Two pharmaceutical giants are locked in the most consequential drug market competition in a generation, fighting for control of the GLP-1 weight loss drug market that is projected to be worth $100 billion in the US alone by 2030.
CDC Declares Obesity a National Crisis: New Federal Guidelines Target America's Most Costly Disease
With 42% of American adults classified as obese and annual healthcare costs exceeding $173 billion, the CDC has declared obesity a national public health crisis and released sweeping new prevention and treatment guidelines.
The American Loneliness Epidemic: Why the US Surgeon General Declared Social Disconnection a Public Health Crisis
US Surgeon General Vivek Murthy has declared loneliness a public health emergency, citing data showing 50% of American adults report measurable loneliness — with physical health consequences comparable to smoking 15 cigarettes daily.
Dementia Prevention Breakthrough: US Study Finds Lifestyle Changes Cut Risk by 45%
A landmark 10-year US clinical trial has identified a combination of five modifiable lifestyle factors that reduce dementia risk by 45% in Americans over 60 — offering the first rigorous evidence that Alzheimer's can be meaningfully prevented.